Semaphorin 7A Induces Liver Inflammation and Promotes Parenteral Nutrition-Associated Cholestasis via ITGβ1/NF-κB Pathway
Archives of Medical Research · 2025
DOI: 10.1016/j.arcmed.2025.103244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Medical Research, 2025. Verfasst von Leilei Shen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Third Military Medical University Southwest Hospital, Chongqing, China. Hauptthemen laut MEDLINE: Semaphorins, Cholestasis, NF-kappa B, Integrin beta1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Army Medical University.
Abstract (Originalsprache)
OBJECTIVE: To investigate the mechanistic role of semaphorin 7A (Sema7A) in neonatal parenteral nutrition-associated cholestasis (PNAC). METHODS: First, we measured the expression levels of Sema7A and inflammatory factors in both neonates with PNAC and rat models. Then, to investigate the mechanism underlying the regulatory role of Sema7A in hepatic inflammatory injury, we assessed NF-κB pathway activation and monitored inflammatory factor variations following Sema7A/integrin β1 (ITGβ1) inhibition and overexpression in rat models and isolated primary Kupffer cells. Furthermore, liver pathology and cholestatic changes were systematically examined by Sema7A manipulation (inhibition and overexpression) in animal models. RESULTS: Neonates and rats with PNAC showed increased levels of TNF-α and IL-1β, and decreased levels of IL-4 and IL-10. Accordingly, Sema7A, ITGβ1, and P65/p-P65 mRNA and protein expression were elevated. In vitro, Sema7A overexpression activated the NF-κB pathway, which was reversible by ITGβ1 inhibition; conversely, Sema7A knockdown attenuated NF-κB activation, which was partially reversible by ITGβ1 overexpression. In vivo, Sema7A overexpression worsened liver injury and cholestasis through activation of the NF-κB pathway, while its inhibition ameliorated these effects. CONCLUSIONS: Sema7A activates the NF-κB signaling pathway in an ITGβ1-dependent manner and exacerbates PN-induced liver injury and cholestasis. Targeting Sema7A may provide a therapeutic strategy to alleviate neonatal PNAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Third Military Medical University Southwest Hospital, Chongqing, China.
- Department of Pediatrics, Third Military Medical University Southwest Hospital, Chongqing, China. Electronic address: chensh129@tmmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Army Medical University
Zitieren
APA
Shen, L., Sun, X., Zheng, R., Tao, M., & Chen, S. (2025). Semaphorin 7A Induces Liver Inflammation and Promotes Parenteral Nutrition-Associated Cholestasis via ITGβ1/NF-κB Pathway. Archives of Medical Research. https://doi.org/10.1016/j.arcmed.2025.103244
Vancouver
Shen L, Sun X, Zheng R, Tao M, Chen S. Semaphorin 7A Induces Liver Inflammation and Promotes Parenteral Nutrition-Associated Cholestasis via ITGβ1/NF-κB Pathway. Archives of Medical Research. 2025. doi:10.1016/j.arcmed.2025.103244
BibTeX
@article{Shen2025,
author = {Shen, Leilei and Sun, Xiaodong and Zheng, Ruixue and Tao, Min and Chen, Sheng},
title = {Semaphorin 7A Induces Liver Inflammation and Promotes Parenteral Nutrition-Associated Cholestasis via ITGβ1/NF-κB Pathway},
journal = {Archives of Medical Research},
year = {2025},
doi = {10.1016/j.arcmed.2025.103244}
}
EUVIMED